186 related articles for article (PubMed ID: 17635910)
21. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
22. Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers.
Lin HK; Hu YC; Yang L; Altuwaijri S; Chen YT; Kang HY; Chang C
J Biol Chem; 2003 Dec; 278(51):50902-7. PubMed ID: 14555644
[TBL] [Abstract][Full Text] [Related]
23. 10-Gingerol Targets Lipid Rafts Associated PI3K/Akt Signaling in Radio-Resistant Triple Negative Breast Cancer Cells.
Ediriweera MK; Moon JY; Nguyen YT; Cho SK
Molecules; 2020 Jul; 25(14):. PubMed ID: 32664351
[TBL] [Abstract][Full Text] [Related]
24. Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways.
Górowska-Wójtowicz E; Hejmej A; Kamińska A; Pardyak L; Kotula-Balak M; Dulińska-Litewka J; Laidler P; Bilińska B
Toxicol In Vitro; 2017 Apr; 40():324-335. PubMed ID: 28163245
[TBL] [Abstract][Full Text] [Related]
25. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
26. MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling.
Cinar B; Collak FK; Lopez D; Akgul S; Mukhopadhyay NK; Kilicarslan M; Gioeli DG; Freeman MR
Cancer Res; 2011 Jun; 71(12):4303-13. PubMed ID: 21512132
[TBL] [Abstract][Full Text] [Related]
27. The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling.
Lamb LE; Zarif JC; Miranti CK
Cancer Res; 2011 Apr; 71(7):2739-49. PubMed ID: 21310825
[TBL] [Abstract][Full Text] [Related]
28. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.
Yang L; Xie S; Jamaluddin MS; Altuwaijri S; Ni J; Kim E; Chen YT; Hu YC; Wang L; Chuang KH; Wu CT; Chang C
J Biol Chem; 2005 Sep; 280(39):33558-65. PubMed ID: 16061480
[TBL] [Abstract][Full Text] [Related]
29. CD40 translocation to lipid rafts: signaling requirements and downstream biological events.
Nadiri A; Polyak MJ; Jundi M; Alturaihi H; Reyes-Moreno C; Hassan GS; Mourad W
Eur J Immunol; 2011 Aug; 41(8):2358-67. PubMed ID: 21567389
[TBL] [Abstract][Full Text] [Related]
30. Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivo.
Thomas C; Lamoureux F; Crafter C; Davies BR; Beraldi E; Fazli L; Kim S; Thaper D; Gleave ME; Zoubeidi A
Mol Cancer Ther; 2013 Nov; 12(11):2342-55. PubMed ID: 23966621
[TBL] [Abstract][Full Text] [Related]
31. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
32. Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer.
Wang Y; Kreisberg JI; Ghosh PM
Curr Cancer Drug Targets; 2007 Sep; 7(6):591-604. PubMed ID: 17896924
[TBL] [Abstract][Full Text] [Related]
33. Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains.
Baron W; Decker L; Colognato H; ffrench-Constant C
Curr Biol; 2003 Jan; 13(2):151-5. PubMed ID: 12546790
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.
Fan W; Yanase T; Morinaga H; Okabe T; Nomura M; Daitoku H; Fukamizu A; Kato S; Takayanagi R; Nawata H
J Biol Chem; 2007 Mar; 282(10):7329-38. PubMed ID: 17202144
[TBL] [Abstract][Full Text] [Related]
35. The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1.
Cinar B; Fang PK; Lutchman M; Di Vizio D; Adam RM; Pavlova N; Rubin MA; Yelick PC; Freeman MR
EMBO J; 2007 Oct; 26(21):4523-34. PubMed ID: 17932490
[TBL] [Abstract][Full Text] [Related]
36. Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinase.
Ding Z; Liang J; Li J; Lu Y; Ariyaratna V; Lu Z; Davies MA; Westwick JK; Mills GB
PLoS One; 2010 Mar; 5(3):e9910. PubMed ID: 20361045
[TBL] [Abstract][Full Text] [Related]
37. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
38. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.
Liu L; Dong X
PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799
[TBL] [Abstract][Full Text] [Related]
39. The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells.
Liu Y; Wu X; Dong Z; Lu S
Int J Oncol; 2010 Mar; 36(3):623-33. PubMed ID: 20126983
[TBL] [Abstract][Full Text] [Related]
40. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
Chesire DR; Ewing CM; Gage WR; Isaacs WB
Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]